Litigation Details for ELI LILLY AND COMPANY v. ACCORD HEALTHCARE INC., USA (S.D. Ind. 2014)
✉ Email this page to a colleague
ELI LILLY AND COMPANY v. ACCORD HEALTHCARE INC., USA (S.D. Ind. 2014)
| Docket | ⤷ Sign Up | Date Filed | 2014-03-12 |
| Court | District Court, S.D. Indiana | Date Terminated | |
| Cause | 35:271 Patent Infringement | Assigned To | Larry J. McKinney |
| Jury Demand | None | Referred To | Magistrate Judge Tim A. Baker |
| Patents | 8,404,703; 8,569,325 | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in ELI LILLY AND COMPANY v. ACCORD HEALTHCARE INC., USA
The small molecule drug covered by the patents cited in this case is ⤷ Sign Up .
Details for ELI LILLY AND COMPANY v. ACCORD HEALTHCARE INC., USA (S.D. Ind. 2014)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 2014-03-12 | 1 | and legally issued United States Patent No. 8,404,703 (“the ’703 patent”), entitled “Medicinal Compositions… and Ube’s United States Patent No. 5,288,726 by Mylan and Nos. 8,404,703 and 8,569,325 by all Defendants… COUNT I: INFRINGEMENT BY ACCORD OF U.S. PATENT NO. 8,404,703 139. Accord USA’s filing of…ACCORD OF U.S. PATENT NO. 8,404,703 145. This count arises under… COUNT V: INFRINGEMENT BY AMNEAL OF U.S. PATENT NO. 8,404,703 173. The filing by Amneal Pharmaceuticals | External link to document | |
| 2014-05-06 | 155 | Attachments: # 1 Exhibit A (U.S. Patent No. 8,404,703), # 2 Exhibit B (U.S. Patent No. 8.569,325))(Zweig, Sally…12 March 2014 1:14-cv-00389-LJM-TAB Patent None District Court, S.D. Indiana | External link to document | |
| 2014-07-18 | 232 | IV certifications as to U.S. Patent Nos. 8,404,703 and 8,569,325 patents to paragraph III certifications…12 March 2014 1:14-cv-00389-LJM-TAB Patent None District Court, S.D. Indiana | External link to document | |
| 2015-03-12 | 304 | on the label (U.S. Patent No. 8,404,703 and 8,569,325 (the ‘703 and ‘325 patents)). The Mylan…active ingredient in Effient® (U.S. Patent No. 5,288,726 (the ‘726 patent)), and methods of using Effient®…that Defendants infringed three of Plaintiffs’ patents by filing an Abbreviated New Drug Application …acute coronary syndrome who receive stents. The patents at issue protect the molecule prasugrel hydrochloride…defendants who challenged the validity of Plaintiffs’ patents that cover Effient®.2 Defendant Mylan, Inc. (“Mylan | External link to document | |
| 2015-04-01 | 311 | Plaintiffs. (Attachments: # 1 Exhibit 1 - US Patent No. 8,404,703, # 2 Exhibit 2 - 703 File History Excerpts…12 March 2014 1:14-cv-00389-LJM-TAB Patent None District Court, S.D. Indiana | External link to document | |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
